Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
223.00    -0.60 (-0.27%)
Bid:
221.20
Ask:
221.60
Spread: 0.40 (0.181%)
Market Cap: £2.19b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Transaction in Own Shares

14 Apr 2022 07:00

RNS Number : 3239I
Serco Group PLC
14 April 2022
 

Serco Group plc 

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

Transactions in own shares

 

Serco Group plc (the 'Company') announces the purchase of 32,986 ordinary shares of 2 pence each (the 'Ordinary Shares') through J.P. Morgan Securities plc on 13 April 2022.

 

The Company intends to hold all of the purchased Ordinary Shares in treasury.

 

Since the announcement of the share buy-back programme on 24 February 2022 (the 'Programme'), the Company has purchased a total of 7,436,441 Ordinary Shares.

 

Following the transactions referred to in this announcement, the Company holds 7,436,441 Ordinary Shares in treasury and has 1,210,572,347 Ordinary Shares in issue (excluding treasury shares). The total number of Ordinary Shares with voting rights will be 1,210,572,347 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The table below contains detailed information about the purchases referred to above.

 

Schedule of Purchases

 

Shares purchased:

Serco Group plc (ISIN: GB0007973794)

 

Date of purchases:

13 April 2022

 

Investment firm:

J.P. Morgan Securities plc

 

Aggregate information:

 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share

Lowest price per share

Highest price per share

London Stock Exchange

32,986

148.6748

147.7000

149.7000

Ends

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com 

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIJMATMTABBJT
Date   Source Headline
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20232:07 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20231:10 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20234:07 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20234:34 pmRNSDirector/PDMR Shareholding
12th Apr 20234:33 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:34 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20231:20 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20231:46 pmRNSNotice of AGM - Replacement
20th Mar 20231:00 pmRNSNotice of AGM
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSTransaction in Own Shares
13th Mar 20237:00 amRNSTransaction in Own Shares
10th Mar 20237:00 amRNSTransaction in Own Shares
9th Mar 202311:47 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20231:00 pmRNSAnnual Financial Report
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 202310:00 amRNSTotal Voting Rights
28th Feb 202311:30 amRNSSerco share repurchase programme
28th Feb 20237:00 amRNS2022 Full Year Results
27th Feb 202310:00 amRNSHolding(s) in Company
23rd Feb 20237:00 amRNSSerco wins CMS rebid valued at $690m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.